Novo Nordisk Stock Share Price Today: Why company's shares are down? Here's Alzheimer drug’s trial outcome, stock market impact, analysts insights

Novo Nordisk stock share price today fell after the company announced that semaglutide, used in Ozempic and Wegovy, failed to slow Alzheimer’s progression in trials. Shares hit a four-year low, continuing a downward trend amid market competition and earlier guidance cuts, raising concerns for investors.